Skip to main content
MyPeptideMatch

SS-31

Phase 3 clinical trials

Mitochondria-Targeting Peptide

Mitochondrial dysfunctionHeart failureAnti-agingRenal protection
MyPeptideMatch Team

SS-31 (Elamipretide, MTP-131) is a tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) that selectively targets the inner mitochondrial membrane to stabilize cardiolipin, reduce electron leak, and restore mitochondrial cristae architecture in aged and failing mitochondria.

Where to Buy SS-31 for Research

Research Use Only — not intended for human consumption

1
Pinnacle Peptide LabsTop Rated
Third-party testedUS-based
View Product
2
Pure Peptides
$50.00
View Product
3
Pharma Grade Peptides
View Product
4
Prime Peptides
$110.00
View Product

Research peptides are sold for laboratory use only and are not intended for human consumption.

Dosing protocol

Protocol

Week-by-week dosing, reconstitution steps, supplies checklist, and cycle tips.

Week-by-week dosing protocol

Find Clinics Offering SS-31

12 clinics in our directory offer SS-31. Use the button below to find one near you.

Find a Peptide Clinic Near You

Continue Reading

Articles about SS-31 and related topics

Why Amazon Removed Bacteriostatic Water — And Where to Buy It Now (2026)
News

Why Amazon Removed Bacteriostatic Water — And Where to Buy It Now (2026)

Amazon quietly delisted bacteriostatic water across 2024–2026 — no press release, no customer notice, listings simply vanished. Behind the removal: a prescription-only label Amazon's policy couldn't accommodate, FDA warning letters turning BAC water into legal evidence of intended human injection use, independent testing that found 9 of 11 Amazon products failed basic quality standards, and a growing wave of sterile water lawsuits that made the liability math untenable. Here is a complete breakdown of what happened and where to get pharmaceutical-grade BAC water now.

Read article
FDA Panel Votes 8–6 to Clear BPC-157, TB-500 & 4 Peptides for Compounding (July 2026)
News

FDA Panel Votes 8–6 to Clear BPC-157, TB-500 & 4 Peptides for Compounding (July 2026)

The FDA's Pharmacy Compounding Advisory Committee voted 8–6 to recommend six popular peptides — including BPC-157 and TB-500 — for the 503A Bulk Drug Substances list. The vote is historic but non-binding: formal FDA rulemaking, which typically takes 8–12 months, must follow before compounding pharmacies have legal authority to prepare them. Here is a complete breakdown of the vote, what it means for access, and what happens next.

Read article
How to Reconstitute BPC-157: Step-by-Step Mixing Guide (2026)
How-To Guides

How to Reconstitute BPC-157: Step-by-Step Mixing Guide (2026)

A detailed, clinician-informed guide to BPC-157 reconstitution — covering diluent selection, step-by-step mixing instructions, concentration math with worked examples, storage requirements, and common mistakes that destroy peptide potency.

Read article

MyPeptideMatch.com does not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy. Regulatory status may change.